Welcome to LookChem.com Sign In|Join Free
  • or
Acetamide, 2-chloro-N-[3-[4-[[3-methyl-4-(3-pyridinyloxy)phenyl]amino]-6-quinazolin yl]-2-propynyl]- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

383430-47-5

Post Buying Request

383430-47-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

383430-47-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 383430-47-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,8,3,4,3 and 0 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 383430-47:
(8*3)+(7*8)+(6*3)+(5*4)+(4*3)+(3*0)+(2*4)+(1*7)=145
145 % 10 = 5
So 383430-47-5 is a valid CAS Registry Number.

383430-47-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-chloro-N-(3-{4-[3-methyl-4-(pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-prop-2-ynyl)-acetamide

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:383430-47-5 SDS

383430-47-5Relevant academic research and scientific papers

Selective erbB2 inhibitor/anti-erbB antibody combinations in the treatment of cancer

-

Page/Page column 18, (2008/06/13)

This invention relates to a method of treatment of cancer with a combination of an erbB2 ligand and an antibody, in mammals. More particularly, this invention relates to a method of treating cancer by administering an erbB2 ligand in combination with an erbB antibody. This invention also relates to a kit useful in the treatment of abnormal cell growth in mammals, especially humans.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 383430-47-5